INRseurannan

INRseurannan is a term used in healthcare to describe the systematic monitoring of the International Normalized Ratio (INR) in patients receiving anticoagulation therapy, such as warfarin. In Finnish medical usage, INR-seuranta refers to practices that track INR values over time and adjust dosing to maintain a therapeutic range. The concept encompasses laboratory testing, dose adjustment, and clinical decision support to minimize the risk of thrombosis and bleeding.

INRseurannan typically involves regular blood tests, either at a clinic or through point-of-care devices, with results reviewed by clinicians and integrated into electronic health records. Many programs also support patient education, standardized dosing algorithms, and, in some settings, remote monitoring and telemedicine to communicate changes in therapy.

Workflow and technology: A patient on anticoagulants with INRseurannan follows a testing schedule determined by stability, concurrent therapies, and guidelines. When INR results fall outside target ranges, the care team may adjust the dose and schedule repeat testing. Digital tools can provide decision support, reminders, and secure data transmission.

History and scope: The practice has long been part of anticoagulation management, expanding with digital health tools in recent decades to improve access and timeliness of monitoring.

Benefits and challenges: Benefits include improved time in therapeutic range and reduced adverse events; challenges include test variability, patient adherence, cost, and data privacy.

See also: INR, warfarin, anticoagulation management, patient self-testing.